PDSB PDSB

PDS Biotechnology Stock Price

5.78
-0.29 (-4.78%)
Upgrade to Real-Time
Regular Market
5.78
Volume 299,441
Bid Price 5.77
Ask Price 5.80
News -
Day High 6.13

Low
2.52

52 Week Range

High
17.85

Day Low 5.55
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
PDS Biotechnology Corporation PDSB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.29 -4.78% 5.78 11:45:33
Open Price Low Price High Price Close Price Prev Close
5.96 5.55 6.13 6.07
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,848 299,441 $ 5.76 $ 1,724,532 - 2.52 - 17.85
Last Trade Time Type Quantity Stock Price Currency
11:45:32 3 $ 5.78 USD

Period:

Draw Mode:

PDS Biotechnology Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 164.37M 28.44M 27.11M $ - $ - -0.95 -11.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 205.90k 10.40%

more financials information »

PDS Biotechnology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PDSB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.806.895.556.37362,325-1.02-15.0%
1 Month8.938.955.557.38363,928-3.15-35.27%
3 Months12.1112.83655.559.19370,012-6.33-52.27%
6 Months9.5117.855.5511.57424,084-3.73-39.22%
1 Year2.8417.852.527.991,085,6202.94103.52%
3 Years8.1617.850.61535.50705,416-2.38-29.17%
5 Years8.1617.850.61535.50705,416-2.38-29.17%

PDS Biotechnology Description

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.


Your Recent History
NASDAQ
PDSB
PDS Biotec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.